Literature DB >> 15460907

Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma.

Satoru Imura1, Hidenori Miyake, Keisuke Izumi, Seiki Tashiro, Hisanori Uehara.   

Abstract

Tumor-associated angiogenesis is essential for tumor growth or metastasis, and consists of multiple and sequential steps regulated by proangiogenic and antiangiogenic factors. Vascular endothelial cell proliferation is involved in this process. We investigated the correlation of vascular endothelial cell proliferation with microvessel density (MVD) and expression of major proangiogenic molecules, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in hepatocellular carcinoma (HCC). Formalin-fixed paraffin-embedded specimens of surgically resected HCC from 67 patients were used. Proliferating endothelial cells were detected by immunofluorescence double staining for CD34 and proliferating cell nuclear antigen (PCNA). The proliferation activity of endothelial cells was determined by the rate of PCNA-positive endothelial cells, and evaluated at the periphery and center of the tumors and adjacent non-neoplastic livers. MVD and the expression of VEGF and bFGF in the tumors were also examined immunohistochemically. The proliferation activity of endothelial cells at the periphery of the tumors was significantly higher than that at the center of the tumors (35.8% vs. 12.7%, P<0.0001). The rate of PCNA-positive endothelial cells in the tumors with higher bFGF expression was significantly higher than that in the tumors with lower bFGF expression (44.8% vs. 32.5%, P<0.005) at the periphery of the tumors. There was no significant correlation between the rate of PCNA-positive endothelial cells and clinicopathological findings or MVD. In HCC, the proliferation activity of vascular endothelial cells is suggested to be heterogeneous in the tumor and higher at the periphery of the tumor, and bFGF may play an important role in the positive regulation of tumor-associated vascular endothelial cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460907     DOI: 10.2152/jmi.51.202

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  18 in total

1.  Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC).

Authors:  R A Pazo-Cid; M Lanzuela; G Esquerdo; J L Pérez-Gracia; A Antón; G Amigo; J Martínez Trufero; A L García-Otín; P Martín-Duque
Journal:  Clin Transl Oncol       Date:  2012-07-18       Impact factor: 3.405

Review 2.  Cancer gene discovery in hepatocellular carcinoma.

Authors:  Lars Zender; Augusto Villanueva; Victoria Tovar; Daniela Sia; Derek Y Chiang; Josep M Llovet
Journal:  J Hepatol       Date:  2010-03-20       Impact factor: 25.083

3.  Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.

Authors:  Sheau-Fang Yang; Shen-Nien Wang; Chih-Fung Wu; Yao-Tsung Yeh; Chee-Yin Chai; Shih-Chang Chunag; Maw-Chang Sheen; King-Teh Lee
Journal:  J Clin Pathol       Date:  2006-08-10       Impact factor: 3.411

4.  Effect of c-fos antisense probe on prostaglandin E2-induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells.

Authors:  Yong-Qi Li; Kai-Shan Tao; Ning Ren; Yi-Hu Wang
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

5.  Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.

Authors:  Ivan Chebib; Meer Taher Shabani-Rad; Michelle S Chow; James Zhang; Zu-Hua Gao
Journal:  Biomark Insights       Date:  2007-02-14

6.  Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.

Authors:  Oszkar Szentirmai; Cheryl H Baker; Szofia S Bullain; Ning Lin; Masaya Takahashi; Judah Folkman; Richard C Mulligan; Bob S Carter
Journal:  J Neurosurg       Date:  2008-05       Impact factor: 5.115

7.  The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer.

Authors:  Carolyn A Staton; Andrew S A Chetwood; Iain C Cameron; Simon S Cross; Nicola J Brown; Malcolm W R Reed
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

8.  Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.

Authors:  Ewa Janczewska-Kazek; Bogdan Marek; Dariusz Kajdaniuk; Halina Borgiel-Marek
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

9.  Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.

Authors:  Atsushi Nanashima; Toshiyuki Nakayama; Yorihisa Sumida; Takafumi Abo; Hiroaki Takeshita; Kenichirou Shibata; Shigekazu Hidaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

10.  Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.

Authors:  Benjamin Okyere; Miranda Creasey; Yeonwoo Lebovitz; Michelle H Theus
Journal:  J Neurosci Methods       Date:  2017-09-18       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.